Picture of Dare Bioscience logo

DARE — Dare Bioscience News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Daré Bioscience Announces Findings For The Treatment Of Menopausal Symptoms From A Phase 1/2 Clinical Trial Of DARE-HRT1 Intravaginal Rings

Aug 9 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES PUBLICATION IN THE JOURNAL OF
THE
NORTH AMERICAN MENOPAUSE SOCIETY OF POSITIVE EFFICACY FINDINGS
FOR THE TREATMENT OF MENOPAUSAL SYMPTOMS FROM A PHASE 1/2
CLINICAL TRIAL OF DARE-HRT1 INTRAVAGINAL RINGS

Source text for Eikon:  ID:nGNX2PXlgx 
Further company coverage:  DARE.O

Recent news on Dare Bioscience

See all news